Literature DB >> 30740439

Case closed: another prophylactic cranial irradiation trial for stage 3 non-small cell lung cancer fails to improve overall survival.

Nuriel Moghavem1, Heather A Wakelee2, Seema Nagpal1.   

Abstract

Entities:  

Year:  2018        PMID： 30740439      PMCID： PMC6330621          DOI： 10.21037/atm.2018.12.24

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  21 in total

1.  The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.

Authors:  Christina A Meyers; Jeffrey S Wefel
Journal:  J Clin Oncol       Date:  2003-08-11       Impact factor: 44.544

2.  Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

Authors:  Elizabeth M Gore; Kyounghwa Bae; Stuart J Wong; Alexander Sun; James A Bonner; Steven E Schild; Laurie E Gaspar; Jeffery A Bogart; Maria Werner-Wasik; Hak Choy
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

3.  Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.

Authors:  M Stuschke; W Eberhardt; C Pöttgen; G Stamatis; H Wilke; G Stüben; F Stöblen; H H Wilhelm; H Menker; H Teschler; R D Müller; V Budach; S Seeber; H Sack
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

Review 4.  Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review.

Authors:  Jason Francis Lester; Fergus R MacBeth; Bernadette Coles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

5.  Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.

Authors:  N Li; Z-F Zeng; S-Y Wang; W Ou; X Ye; J Li; X-H He; B-B Zhang; H Yang; H-B Sun; Q Fang; B-X Wang
Journal:  Ann Oncol       Date:  2014-12-15       Impact factor: 32.976

6.  Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.

Authors:  Cécile Le Péchoux; Ariane Dunant; Suresh Senan; Aaron Wolfson; Elisabeth Quoix; Corinne Faivre-Finn; Tudor Ciuleanu; Rodrigo Arriagada; Richard Jones; Rinus Wanders; Delphine Lerouge; Agnès Laplanche
Journal:  Lancet Oncol       Date:  2009-04-20       Impact factor: 41.316

7.  Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group.

Authors:  A H Russell; T E Pajak; H M Selim; J C Paradelo; K Murray; P Bansal; J D Cooper; S Silverman; J A Clement
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-08       Impact factor: 7.038

8.  A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.

Authors:  Riccardo Soffietti; Martin Kocher; Ufuk M Abacioglu; Salvador Villa; François Fauchon; Brigitta G Baumert; Laura Fariselli; Tzahala Tzuk-Shina; Rolf-Dieter Kortmann; Christian Carrie; Mohamed Ben Hassel; Mauri Kouri; Egils Valeinis; Dirk van den Berge; Rolf-Peter Mueller; Gloria Tridello; Laurence Collette; Andrew Bottomley
Journal:  J Clin Oncol       Date:  2012-12-03       Impact factor: 44.544

9.  Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.

Authors:  Christoph Pöttgen; Wilfried Eberhardt; Andreas Grannass; Soenke Korfee; Georg Stüben; Helmut Teschler; Georgios Stamatis; Horst Wagner; Bernward Passlick; Volker Petersen; Volker Budach; Hans Wilhelm; Isabel Wanke; Herbert Hirche; Hans-Jochen Wilke; Martin Stuschke
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

Review 10.  Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors.

Authors:  Christina A Meyers; Paul D Brown
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.